Ann Hepatobiliary Pancreat Surg.  2020 Feb;24(1):104-108. 10.14701/ahbps.2020.24.1.104.

First experience of pancreaticoduodenectomy using Revo-i in a patient with insulinoma

Affiliations
  • 1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. CMKANG@yuhs.ac
  • 2Pancreatobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, Seoul, Korea.

Abstract

Robotic surgery systems have been developed to overcome the limitations of laparoscopic surgery. Recently, Meerecompany Inc. in Korea successfully manufactured a robotic surgical system called Revo-i. A 65-year old woman was referred for a pancreatic head tumor, detected as an incidental finding during a routine check-up. Contrast abdominopelvic CT revealed a pancreatic uncinate tumor measuring around 13 mm in diameter, with no other focal lesions. The patient underwent a robot-assisted pancreaticoduodenectomy (laparoscopic resection and robotic reconstruction) using Revo-i. The patient's recovery was uneventful and discharged on postoperative day 7. Our case showed the technical feasibility of the Korean robotic surgical system Revo-i. Further experiences are mandatory to validate this finding.

Keyword

Robotic surgical system; Pancreaticoduodenectomy; Robot surgery

MeSH Terms

Female
Head
Humans
Incidental Findings
Insulinoma*
Korea
Laparoscopy
Pancreaticoduodenectomy*
Full Text Links
  • AHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error